Governor McAuliffe Announces The V Foundation for Cancer Research

 (Photo credit: mdfriendofhillary)

Governor McAuliffe Announces The V Foundation for Cancer Research, Virginia Wine Partnership To Fund Major Cancer Research Initiative

“Virginia Vine: The Commonwealth Crushes Cancer” to take place April 2015; Kick-off Event Today at Executive Mansion

RICHMOND – Governor Terry McAuliffe  announced that Virginia will partner with The V Foundation for Cancer Research to host “Virginia Vine: The Commonwealth Crushes Cancer,” a weekend event to be held in April 2015 at Trump Winery and other locations in Charlottesville.  The V Foundation, one of the nation’s leading cancer research foundations, is partnering with the Virginia wine industry, the University of Virginia (UVA) Cancer Center and the Massey Cancer Center at Virginia Commonwealth University (VCU) to raise critical funds for cancer research.  Governor McAuliffe will host a kick-off event tonight at the Executive Mansion.

Speaking about the new partnership, Governor McAuliffe said, “I am honored to welcome The V Foundation in Virginia to highlight two of our most unique assets – our renowned cancer research programs at UVA and VCU and our highly acclaimed wine industry.  Everyone has been touched in some way by the harsh realities of cancer and I’m certain that this partnership and the “Virginia Vine: The Commonwealth Crushes Cancer” event will provide a new platform to lend our support to tireless efforts to find a cure for cancer and to honor the memory of Coach Jim Valvano and the mission of The V Foundation. This partnership highlights my administration’s effort to make Virginia a global leader in healthcare innovation and will benefit our long-term economic success by working to keep our population healthy and our growing agricultural industry thriving.”

The “Virginia Vine: The Commonwealth Crushes Cancer” event will take place April 17-18, 2015 and will include a Friday evening wine festival and a Saturday afternoon cancer information symposium.  The weekend will conclude with a dinner gala, featuring Virginia wines and local food products, on Saturday evening at Trump Winery.  Each event will focus on funding for cancer research, while highlighting Virginia’s burgeoning wine industry.  More details on the weekend events and the dinner gala, including the announcement of entertainment, will be provided in the coming months. 

“The V Foundation is honored to be a part of Virginia Vine,” said Susan Braun, Chief Executive Officer of The V Foundation.  “Our mission to end cancer is only possible with excellent partners, and this is an extraordinary partnership.  We’re very grateful to Governor McAuliffe and the many people responsible for Virginia Vine!”

Virginia’s efforts to recruit and partner with The V Foundation began in the summer of 2013 during outreach led by Trump Winery, Secretary of Agriculture & Forestry Todd Haymore, Secretary of Health & Human Resources Bill Hazel, and key public and private sector leaders in Charlottesville and Albemarle County.  The outreach led to a series of meetings where The V Foundation found that the Commonwealth’s widely recognized cancer centers at UVA and VCU, growing reputation for producing high quality wines, and mid-Atlantic location, where more than 60% of the nation’s population lives within a day’s drive, would provide a unique opportunity to create a new annual cancer research fundraising event on the East Coast that would highlight Virginia’s acclaimed wine and wine tourism industries.

Secretary Haymore noted, “The Commonwealth’s wine industry has experienced tremendous growth both in quantity and quality in recent years and we’ve been proud to support the industry from the Governor’s office.  That support has allowed Virginia wines and winery tourism to raise their profile both here and abroad.  It has also allowed us to help create new opportunities, such as the “Virginia Vine”partnership with The V Foundation, where we can continue highlighting our outstanding wines and wineries while truly promoting and supporting an outstanding cause, eradicating cancer, a disease that has affected the lives of so many.”

Secretary Hazel added, “This event will allow the Commonwealth to leverage our research assets and investments to help raise important dollars for cancer research through The V Foundation.  University of Virginia Cancer Center and VCU Massey Cancer Center are Virginia’s only two National Cancer Institute (NCI)-designated cancer centers, placing them among the top five percent of all cancer centers in the U.S.  These partners are a natural fit for The V Foundation and the“Virginia Vine” event will bring more awareness to our collective ongoing efforts to prevent, detect, treat, and control cancer to enhance the quality of life of all those affected by this disease.”

In order to create the foundation for a successful annual event, work is already underway for next year’s Virginia Vine celebration.  Beginning with the kick-off event today, Governor McAuliffe, Secretary Haymore, Secretary Hazel, the Virginia Wine Marketing Office, the Virginia Tourism Corporation, local chefs and restaurants, Virginia’s best-in-class cancer centers, and others will be working in tandem to promote the event over the course of the next year at various wineries across the Commonwealth.

About The V Foundation for Cancer Research

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State basketball coach and ESPN commentator. Since 1993, The Foundation has funded more than $115 million in cancer research grants nationwide. It awards 100 percent of all direct cash donations to cancer research and related programs. Due to generous donors, the Foundation has an endowment that covers administrative expenses. The Foundation awards peer-reviewed grants through a competitive awards process strictly supervised by a Scientific Advisory Committee. For more information on The V Foundation, please visit www.jimmyv.org.

About the Virginia Wine Industry

Sales of Virginia wine reached a record high in fiscal year 2013 with more than 511,000 cases, or more than 6.1 million bottles, sold. Virginia currently ranks fifth in the number of wineries in the nation with 250 wineries. Virginia is also tied with Texas as the nation’s fifth largest wine grape producing state.  Virginia wineries experienced more than 1.6 million visitors during 2012, the last year where full data is available.  According to a recent economic impact study, the Virginia wine industry employs more than 4,700 people and contributes almost $750 million to the Commonwealth’s economy on an annual basis.  For more information on the Virginia wine industry, please click here.

Related articles

• Governor McAuliffe Announces Third Microsoft Expansion in Mecklenburg County
• Governor McAuliffe Announces Decrease in Homelessness
• Governor McAuliffe Kicks Off Inaugural Meeting of the Virginia Cyber Security Commission
• Governor McAuliffe Announces June as Business Appreciation Month
• Governor McAuliffe Welcomes Air China Inaugural Nonstop Flight at Washington Dulles Airport
• Governor McAuliffe Announces Virginia's Grant Award for Veterans' Job Training

Governor McAuliffe Names 5 Members to Virginia Port Authority Board of Commissioners

(Photo credit: Wikipedia)

Today at a news conference in Norfolk, Governor Terry McAuliffe announced that he has named 5 Virginia business and transportation leaders to the Virginia Port Authority’s Board of Commissioners. The Governor has asked the incoming members, who will serve the unexpired terms of 5 previous members of the board, to act swiftly to improve the port’s fiscal management and return it to profitability.

“The Port of Virginia is one of the Commonwealth’s most important economic assets, and improving its performance is one of my top priorities,” said Governor McAuliffe. “This team of Virginia leaders has the right experience and vision to strengthen the Port financially and put it on the path toward long-term, sustainable growth.

“I know they are just as eager as I am to work alongside the dedicated men and women of the Port Virginia to make it stronger and better prepared to succeed in a 21^st Century economy.”

The new members of the Virginia Port Authority Board of Commissioners and their brief bio’s are below:

G. Robert Aston, Jr., Portsmouth

 The Chairman of the Board and Chief Executive Officer of TowneBank, which he founded in 1998,  Bob Aston is a professional banker with forty – nine years of successful leadership in community banks and a super regional bank, including twenty – nine years experience as  President and CEO. He served as President and Chief Executive Officer of BB&T of Virginia from January 1995 to June 1998 and as President and Chief Executive Officer of Commerce Bank from April 1985 to January 1995.  Mr. Aston began his career at Citizens Trust Company in 1964 and rose through the ranks to serve as President and Chief Executive Officer from 1981 to 1985.

 Aston also has long record of community service which includes time as past Director of Virginia International Terminals, Inc. Currently, Aston serves on a host of boards and foundations in the community including as the President and Chairman of the Eastern Virginia Medical School Foundation and as a Fort Monroe Authority trustee. Aston is a graduate of the National Installment Lending School at the University of Oklahoma and the Graduate School of Retail Banking at the University of Virginia.

Alan Diamonstein, Newport News

Alan Diamonstein has an outstanding record as a former elected official representing the Virginia Peninsula for more than 30 years, and as an attorney and statewide leader for initiatives that have improved every community in the Commonwealth.

 As a partner in the Patten, Wornom, Hatten, Diamonstein law firm, he specializes in public policy issues and project finance, economic development law and real estate ventures. Major projects in which he has been involved include large commercial and retail properties, planned housing communities and the location and development of successful solid waste management facilities in the southern regions of the United States.

 He is a past member of the University of Virginia Board of Visitors, and has served as chairman of the internationally recognized Mariners’ Museum in Newport News.

 As a senior member of the Virginia House of Delegates, he served as the chairman of several key legislative committees, and was a budget conferee on the Appropriations Committee for many years. He is widely recognized for his support of Virginia’s college and university system and the housing industry. He served on several Presidential Commissions and led the Virginia Housing Study Commission for more than 20 years.

 He attended the University of Virginia, and, after completing a tour with the U.S. Air Force, received his B.S. degree in commerce. He earned his law degree at the University of Virginia Law School. He received an Honorary Doctor of Laws degree from Christopher Newport University and an Honorary Doctor of Laws degree from the College of William and Mary.

 Gary T. McCollum, Virginia Beach

 Gary T. McCollum is the Senior Vice President and General Manager for Cox Communications. He was appointed to oversee all Cox operations in Hampton Roads, Northern Virginia & Roanoke in February 2010.  Cox Virginia’s network reaches approximately 777,000 homes through the Commonwealth and has approximately 2,300 employees.

 Gary joined Cox Communications in 1989 as a manager trainee in Hartford, Connecticut, and was later promoted to a variety of management roles, including Plant Operations Manager, Director of Network Development, and Vice President of Customer Care.  Gary went on to serve as Vice President and General Manager for Cox’s Roanoke, Virginia cable system, spearheading efforts to bring the Information Superhighway to all segments of the community. In 2000, Gary was promoted to Vice President and General Manager of Cox’s newly acquired Northern Virginia system.  In 2006, Gary was promoted to lead the Cox Hampton Roads system and then led the consolidation of all locations into one Virginia operation.

 Prior to joining Cox, Gary served eight years on active duty as a military intelligence officer for the U.S. Army and is currently a Major in the U.S. Army Reserves.  During his active duty military career, he served with the elite U.S. Army Rangers.

 Born in a housing project in Richmond, VA, Gary was the first member of his family to graduate from college.   He graduated from James Madison University with a BA in Russian Studies and Political Science, and from the University of Connecticut with an MBA, where he concentrated on telecommunications. 

Val McWhorter, Fairfax

Val McWhorter is a founding partner of the Tysons  Corner based law firm of Smith, Patcher, McWhorter. McWhorter has focused his practice in the area of Construction law for 30 years. His practice has included representing contractors in large, complex claims arising under federal, state, and local government contracts, as well as contracts between private parties.  Mr. McWhorter has engaged in substantial litigation before various Federal Boards of Contract Appeals, Federal Courts and State Courts. He has also served as an advocate in the mediation of construction contract disputes before numerous mediators involving a wide variety of projects.

McWhorter served on the Commission on Higher Education Board Appointments under Governor Tim Kaine and on the State Council of Higher Education during the administration of Governor L. Douglas Wilder. He is also a former member of the George Mason University Board of Visitors.

McWhorter received his Bachelor of Science and Juris Doctorate from Washington & Lee University.

 John G. Milliken, Arlington

 Mr. John G. Milliken serves as a Partner with Venable LLP. In 2013, Milliken Co-Chaired Governor – Elect Terry McAuliffe’s Transition Committees on Commerce and Trade and Transportation.  Mr. Milliken served as the Director of Transition for former Governor Mark R. Warner.  He is a former Secretary of Transportation and formerly served on the  Board of Commissioners at Virginia Port Authority from 2002 – 2011. Milliken served on the Arlington County Board from 1981 -1990 and was the Chair in 1984. Milliken is also a former member of the Washington Metropolitan Area Transit Authority.

Milliken is a graduate of Haverford College and received his Juris Doctorate from the University of Virginia School of Law.

Related articles

• Governor McAuliffe Announces 70 New Jobs in City of Hopewell
• Governor McAuliffe Announces Successful Launch of DMV/VDH Vital Records Partnership
• Governor McAuliffe and First Lady To Open Executive Mansion in Celebration of Virginia Historic Garden Week
• Governor McAuliffe's Statement on the Budget Impasse
• Governor McAuliffe Signs Legislation Helping Bristol Move Forward on Economic Development Project
• Governor McAuliffe Announces Recipients of the 2014 Governor's Volunteerism and Community Service Awards

Governor McAuliffe Announces Two Appointments to ABC Board and Reappointment of 17 Agency Heads

 (Photo credit: Wikipedia)

Today Governor Terry McAuliffe announced the appointments of Boyd Marcus and Jeffrey Painter to the Virginia Alcoholic Beverage Control Board and the reappointment of  17 agency heads across his administration. The appointees will join an administration focused on finding common ground on issues that will grow Virginia’s economy and create jobs across the Commonwealth.

Alcoholic Beverage Control Board

Boyd Marcus

From 1998-2001 Boyd Marcus served as Chief of Staff to Governor James Gilmore III.  In 2002, Marcus served as Chief of Staff to Congressman Eric Cantor. He also served as Chief of Staff to Congressman Tom Bliley, 1981-1988. A native of Leesburg, Virginia, Boyd graduated from the University of Virginia in 1974.

Jeffrey Painter

Jeff Painter is a native of Page County and has over twenty years of senior executive leadership experience in the public and private sector.  His service includes: Executive Director of the Virginia League of Conservation Voters; Chief Administrative Officer of the Virginia Department of Alcoholic Beverage Control Board; and owner of Property Partners, a small business managing and investing in vacation properties. Jeff graduated from Emory and Henry College.

Governor McAuliffe also announced today the reappointment of the following agency heads from across state government:

Randall Burdette, Executive Director of the Department of Aviation

Craig Burns, State Tax Commissioner, Department of Taxation

Colonel W. Steven Flaherty, Superintendent of Virginia State Police

Manju Ganeriwala, State Treasurer, Department of the Treasury

Richard Holcomb, Commission of the Department of Motor Vehicles

Raymond Hopkins, Commissioner of the Department for the Blind and Vision Impaired

Dennis Johnson, Director of the Division of Selected Agency Support Services in the Office of the Governor

Cynthia Jones, Director of the Department of Medical Assistance Services

Ronald Lanier, Director of the Department for the Deaf and Hard of Hearing

Samuel Nixon, Chief Information Officer, Virginia Information Technologies Agency

David Paylor, Director of the Department of Environmental Quality

James Rothrock, Commissioner of the Department for Aging and Rehabilitation Services

William Shelton, Director of the Department of Housing and Community Development

Richard Sliwoski, Director of the Department of General Services

Daniel Timberlake, Director of the Department of Planning and Budget

David Von Moll, State Comptroller, Department of Accounts

Sara Wilson, Director of the Department of Human Resource Management

Related articles

• Governor McAuliffe Announces Telos Corporation to Create 160 New Virginia Jobs
• Look Who's Getting a Job From Governor McAuliffe!
• Governor Terry McAuliffe Executive Order Number 1
• Governor McAuliffe Announces Carnival Cruise Lines' Return to Virginia
• Governor Terence R. McAuliffe Inaugural Address
• Governor McDonnell Announces Agreement to Create New State Park in Loudoun County

Two Virginia Universities in Top Five of Kiplinger’s “Best Values in Public Colleges” Rankings

The David Student Union at Christopher Newport University (Photo credit: Wikipedia)

UVa Remains 2nd in Nation; William and Mary Keeps Number 4 Ranking

James Madison, Virginia Tech, Mary Washington, George Mason, and Christopher Newport Included in the Top 100

RICHMOND – Two Virginia public universities are ranked in the Top 5 of Kiplinger Magazine’s annual ranking of the “Best Values in Public Colleges.” The University of Virginia was ranked second, while The College of William and Mary stayed at number four.  Five other Virginia universities also ranked in the magazine’s top 100, including James Madison University (22), Virginia Tech (27), The University of Mary Washington (61), George Mason University (72), and Christopher Newport University (84).

Speaking about the rankings, Governor McDonnell said, “Once again, Kiplinger saw what Virginians have long known: our colleges and universities provide world-class educations while keeping higher education affordable. Kiplinger specifically noted that UVa has the highest four year graduation rate on its list and the second lowest in-state cost, an average of $5,070 after need based aid is applied. This further demonstrates our commitment to making higher education more affordable and accessible. Over the past four years we have put nearly $600 million in new funding into higher education, including the $183.1 million for fiscal year 2015/2016; we know that helping Virginia students access our great colleges and universities is crucial to their future professional success and the future prosperity of our Commonwealth. Over the next few years we will continue our commitment to higher education by including over $183.1 million in the upcoming biennial budget to ensure that the nation’s best higher education system is even more affordable and accessible for Virginia students.”

The entire Kiplinger ranking is available online here.

The governor’s proposed funding for higher education in the upcoming biennial budget was announced earlier today and can be found here.

Related articles

• Statement of Governor Bob McDonnell on Selection of Dr. Timothy Sands as Next President of Virginia Polytechnic Institute and State University
• Governor McDonnell Announces Appointments to Norfolk State University Board of Visitors
• Governor McDonnell Announces General Tickets Now Available for Governor's Holiday Hoops Classic
• Governor McDonnell's Biennial Budget to Continue Commitment to Improving Virginia's Prisoner Re-Entry and Restoration of Rights Processes
• Governor McDonnell Announces Board and Commission Appointments
• Governor McDonnell Announces Additional Appointment to Administration and Board and Commission Appointments

FDA Pertussis Vaccine Study Shatters Illusion of Vaccine-Induced Immunity

Bordetella pertussis on Charcoal Agar - detail (Photo credit: Nathan Reading)

By Dr. Mercola

Recent vaccine research again reveals the gulf between what you’re told about vaccines—how they work and how effective they are at preventing infectious disease—versus what is truly known about naturally acquired and vaccine acquired immunity.

Nearly a century after the release of the whooping cough (B. pertussis) vaccine, mounting evidence suggests that widespread mandated use of the vaccine could potentially be doing more harm than good in the long term—in addition to having been found lacking in the effectiveness department. As reported by The Washington Post:1

“The research suggests that while the vaccine may keep people from getting sick, it doesn’t prevent them from spreading whooping cough — also known as pertussis — to others.

‘It could explain the increase in pertussis that we’re seeing in the US,’ said one of the researchers, Tod Merkel of the Food and Drug Administration...

Last year was the nation’s worst year for whooping cough in six decades— US health officials received reports of more than 48,000 cases, including 18 deaths... Some studies have concluded the newer vaccine doesn’t last as long as the old one. But the study by Merkel and his colleagues offers a new wrinkle.”

New ‘Wrinkle’ Busts Major Hole in Pro-Mandatory Vaccination Argument

The “new wrinkle” revealed in the featured FDA baboon study is that while the vaccine can cut down on serious clinical disease symptoms, it doesn’t eliminatetransmission of the disease.2 This busts a major hole in the entire argument that vaccines achieve herd immunity, which is used as justification for mandatory vaccination campaigns.

According to the Washington Post:3

“'[I]t was thought that people only spread the disease when they had coughs and other symptoms,' said Dr. Erik Hewlett, a University of Virginia whooping cough researcher who was not involved in the FDA study but has collaborated with Merkel.

Health officials have sought to protect small children by vaccinating the people who are in contact with them such as grandparents and baby sitters— a strategy called ‘cocooning.’ But that may not work as well as hoped if infected people who don’t show any symptoms can still spread it, the research suggests. ‘This is a whole new way of thinking of the problem,’ Hewlett said.”

Whooping Cough Vaccination Makes You an ‘Asymptomatic Carrier’

The study, titled: “Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model,”4 used infant baboons to test the hypothesis that "current acellular pertussis vaccines fail to prevent colonization and transmission" of B. pertussis.

The acellular pertussis vaccines that were licensed in 1996 for infants to replace reactive whole-cell pertussis vaccines contain lower levels of certain toxins (such as endotoxin) as well as purified antigens instead of all the components of whole killed B. pertussis bacteria.

The study concluded that infant baboons given Sanofi DTaP (Daptacel) vaccine at two, four, and six months of age were protected against developing outward clinical symptoms of pertussis after being exposed to B. pertussis at seven months of age, but they were still able colonize and transmit B. pertussis to other baboons.

The baboons that were vaccinated with whole cell pertussis (GlaxoSmithKline's Infanrix) also colonized B. pertussis upon exposure to B. pertussis, but they cleared the infection much faster than the acellular pertussis vaccinated baboons—in 18 days compared to 35 days.

Now, the researchers did not say that DTaP vaccine causes vaccine strain pertussis infection. B. pertussis vaccines (both whole cell DPT and acellular DTaP/Tdap) are inactivated vaccines and do not cause vaccine strain infection the way some attenuated live virus vaccines can—such as live oral polio (OPV) and varicella zoster (chickenpox) vaccines.

However, the lead author Tod Merkel did comment to the New York Times5 that when exposed to B. pertussis after recently getting vaccinated, you could be an asymptomatic carrier and infect others, saying:

“When you’re newly vaccinated, you are an asymptomatic carrier, which is good for you, but not for the population.”

Pertussis Vaccine May Not Curb Transmission of Illness

According to the researchers, acellular pertussis vaccine (Daptacel) induces high antibody titers, which is used to measure efficacy. Whole cell DPT (Infanrix) and natural B. pertussis infection also induce high antibody titers.

But, while acellular pertussis vaccinated baboons did not develop serious clinical disease symptoms—such as loss of appetite and cough—when they were directly challenged with B. pertussis (meaning exposed to the B. pertussis bacteria), they still colonized B. pertussis in their throats and were capable of transmitting the infection to other baboons.

Since acellular pertussis (DTaP) vaccines are the only type of pertussis vaccines now given to American children at the ages of two, four, six and 15-18 months, as well as between the ages of four and six years and at 11-12 years, the researchers said:

"These data suggest that cocooning is unlikely to be an effective strategy to reduce the burden of pertussis in infants. However, it is important to note that our data in combination with human data show that vaccination with acellular pertussis provides excellent protection from severe pertussis.

Therefore, any short-term plan for addressing the resurgence of pertussis should include continued efforts to enhance acellular pertussis immunization. However, to protect the most vulnerable members of the population and achieve optimal herd immunity, it will be necessary to develop a vaccination strategy that effectively blocks pertussis infection and transmission."

What You Need to Know About ‘Herd Immunity’

The issue of “herd immunity” as it pertains to vaccinations is a widely misunderstood subject. The National Institute of Allergy and Infectious Diseases describes vaccine-induced herd immunity (also labeled “community immunity” by public health doctors) as follows:6

“When a critical portion of a community is immunized against a contagious disease, most members of the community are protected against that disease because there is little opportunity for an outbreak. Even those who are not eligible for certain vaccines—such as infants, pregnant women, or immunocompromised individuals—get some protection because the spread of contagious disease is contained. This is known as ‘community immunity.’"

What many people don’t realize is that there is such a thing as natural herd immunity. The problem is that public health officialsassume that vaccines will work the same way. However, vaccines do not confer the same kind of immunity as experiencing and recovering from the natural disease.

The science clearly shows that there's a big difference between naturally acquired herd immunity and vaccine-acquired herd immunity, even as scientific knowledge about the biological mechanisms involved in naturally acquired and vaccine acquired immunity is incomplete. These facts are usually ignored because to openly acknowledge them opens the door to some very unwelcome questions about the overall effectiveness of mandatory vaccination programs.

Vaccines are designed to trick your body's immune system into producing an immune response that includes making protective antibodies that are needed to resist future exposure to the infectious viral or bacterial microorganism. However, your body is smarter than that. The artificial manipulation of your immune system by vaccines containing lab altered bacteria and viruses, as well as chemicals and other ingredients, simply does not exactly replicate the response that your immune system mounts when naturally encountering the infectious microorganism. This is one reason why vaccine policymakers say you need to get “booster” shots because vaccine acquired immunity is only temporary and wears off, sometimes rather quickly.

The featured study also provides evidence of this fact, showing that a vaccine-induced immune response differs from the immune response when naturally encountering the B. pertussis organism. The FDA researchers further suggested that there are also differences in immune responses to whole cell DPT vaccine, which contains the whole B. pertussis bacteria, and acellular pertussis vaccine, which contains lower levels of toxins and uses purified antigens. They said “Vaccination with wP [whole cell pertussis vaccine] and previous infection induced a more rapid clearance compared with naïve and aP[acelullar pertussis[-vaccinated animals.”

As reported by Medical Daily:7

“The researchers also found something revealing when they looked at the specific immune response of each group of monkeys. 'Although all vaccinated and previously infected animals had robust serum antibody responses, we found key differences in T-cell immunity,' the authors wrote in PNAS.

Specifically, previously infected animals and whole-cell-vaccinated animals both exhibited the same kind of boost in immune response while the acellular pertussis vaccination elicited a response that was slightly different. 'The observation that acellular pertussis, which induces an immune response mismatched to that induced by natural infection, fails to prevent colonization or transmission, provides a plausible explanation for the resurgence of pertussis...'"

Although the FDA researchers say they found differences between immune responses to the whole cell DPT vaccine acellular DTaP vaccine, they also admit that “neither vaccine was able to prevent colonization as well as immunity from a previous infection” and that “relative protection afforded by Th17 or Th1 responses in vaccinated or convalescent baboons or humans is not known.”

Bottom line: there are huge gaps in scientific knowledge about both B. pertussis vaccination and B. pertussis infections.

Which Is More Ideal—Permanent or Temporary Immunity?

To learn more, I urge you to listen to the following video, in which Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center (NVIC), discusses the concept of herd immunity. In it, she brings up some very important questions that need to be seriously considered and answered through rigorous scientific investigation—investigation that has so far been largely ignored:

" In most cases natural exposure to disease would give you a longer lasting more robust qualitatively superior immunity because it gives you both cell mediated immunity and humoral immunity... The fact that manmade vaccines cannot replicate the body's natural experience with the disease is one of the key points of contention between those who insist that mankind cannot live without mass use of multiple vaccines and those who believe that mankind's biological integrity will be severely compromised by their continued use.

The fact that manmade vaccines cannot replicate the body's natural experience with the disease is one of the key points of contention between those who insist that mankind cannot live without mass use of multiple vaccines and those who believe that mankind's biological integrity will be severely compromised by their continued use.

... [I]s it better to protect children against infectious disease early in life through temporary immunity from a vaccine, or are they better off contracting certain contagious infections in childhood and attaining permanent immunity? Do vaccine complications ultimately cause more chronic illness and death than infectious diseases do? These questions essentially pit trust in human intervention against trust in nature and the natural order, which existed long before vaccines were created by man."

Download Interview Transcript

What We Don’t Understand Can Hurt Us

My main point of contention with those who insist that vaccines are the best answer for disease prevention, without regard for constitutional differences between people, is that the science is still grossly lacking when it comes to safety. We simply do not know if vaccination is an ideal choice for all people, all the time—even though that’s what public health officials and others promoting one-size-fits all mandatory vaccination policies would like you to believe. The evidence weighs rather heavily againstsuch a blanket position, in my opinion.

Take the recent news of healthy teenagers dying following flu vaccination for example. In January of this year, a 14-year old Carly Christenson passed away from complications from influenza type-A, despite being vaccinated against the flu.8

Most recently, healthy 19-year old Chandler Webb became violently ill the day after receiving a flu shot—the first flu shot he had ever received.9, 10 His symptoms included violent shaking, headache and vomiting. He was hospitalized with encephalitis (brain inflammation). As the swelling of his brain progressed, Chandler’s doctors frantically tested him for various infectious diseases and treated him with broad spectrum antibiotics. Apparently, they did not think to consider whether he’d been recently vaccinated. His brain became so inflamed that doctors told his mother the massive swelling crushed his brain stem. He died 28 days after his first and last dose of influenza vaccine.

Chandler’s mother wants to raise awareness about the potential of vaccines to cause serious complications like brain inflammation and is urging medical personnel to consider vaccine reactions when searching for potential causes and treating encephalitis and other possible vaccine-related health problems. In this case, the doctors are now claiming they were not able to confirm the cause of Chandler’s death, and are declining to comment because they say they are legally prohibited from making any statements about the case.11

Main Take-Home Points and Limitations of the Latest Pertussis Vaccine Study

To recap, FDA researchers conducting the featured baboon study found that the whole cell pertussis vaccine (GSK's Infanrix DPT), the acellular pertussis vaccine (Sanofi's Daptacel DTaP), and natural pertussis infection all induced high antibody titers in infant baboons. High antibody titer after vaccination is currently the gold standard for proving that a vaccine confers “immunity” and inability to colonize or transmit infection.

However in this study, high B. pertussis antibody titers after vaccination did NOT correlate with immunity and inability to colonize or transmit B. pertussis infection to other baboons—effectively challenging the idea that high antibody titer following vaccination is evidence that vaccination will prevent infection in the vaccine recipient and the recipient will not be able to infect others. Furthermore, the study authors found that:

• Baboons vaccinated with a whole cell pertussis vaccine (DPT) colonized B. pertussis upon direct challenge but cleared infection almost twice as fast as animals vaccinated with an acellular pertussis vaccine (DTaP)—which is the type used by American children since 1996. This suggests that children recently given DTaP vaccine, who are exposed to B. pertussis may be astymptomatic carriers and transmitters of the infection for a longer period of time compared to children who get the older, more reactive whole cell DPT vaccine and clear infection more quickly.
• Previous B. pertussis infection prevented colonization with B. pertussis in baboons better than having received either whole cell pertussis (Infanrix) or acelullar pertussis vaccine (Daptacel). In short, natural immunity offered greater protection against the ability to become infected and transmit infection after exposure to B. pertussis than either of the two vaccines.

That said, the researchers acknowledged the baboon study had limitations and among them were the fact that:

• Baboons are not humans and the study authors admitted that "relative protection afforded by Th17 and Th1 responses in vaccinated or convalescent baboons or humans is not known."
• Only one type of whole cell DPT and one type of acellular DTaP vaccine was used in this study but there are many different kinds of DPT and DTaP containing different components. Considering the known variability of measured efficacy and effectiveness of DPT and DTaP vaccines in clinical studies, the FDA study conclusions can only be limited to those two specific DPT and DTaP vaccines.

The Illusion of Vaccine-Acquired Immunity

The concept of vaccine induced herd immunity is built on the assumption that vaccination does protect the vast majority of vaccinated persons in a population from becoming infected with- and transmitting infection to others in the same way that naturally acquired immunity in a population protects acquisition and transmission of infection. The featured FDA research suggests this is not the case and offers a clue as to why whooping cough outbreaks have been occurring and spreading primarilywithin the vaccinated population. To quote NVIC’s Barbara Loe Fisher:

“In my opinion, this study in infant baboons suggests that pertussis vaccine-acquired immunity has been an illusion. Although the vaccines may protect against severe B. pertussis clinical symptoms of the disease—such as paroxysmal coughing—they do not prevent colonization of B. pertussis bacteria and transmission of the infection to others.

In this study at least, recovery from previous B. pertussis infection was more effective in preventing colonization with B.pertussis upon direct challenge than either whole cell DPT (Infanrix) or acellular DTaP (Daptacel) and that suggests transmission of the infection to others after exposure to B pertussis would also be less likely when there is a history of naturally acquired immunity.”

Protect Your Right to Informed Consent and Defend Vaccine Exemptions

With all the uncertainty surrounding the safety and efficacy of vaccines, it's critical to protect your right to make independent health choices and exercise voluntary informed consent to vaccination. It is urgent that everyone in America stand up and fight to protect and expand vaccine informed consent protections in state public health and employment laws. The best way to do this is to get personally involved with your state legislators and educating the leaders in your community.

THINK GLOBALLY, ACT LOCALLY.

National vaccine policy recommendations are made at the federal level but vaccine laws are made at the state level. It is at the state level where your action to protect your vaccine choice rights can have the greatest impact. It is critical for EVERYONE to get involved now in standing up for the legal right to make voluntary vaccine choices in America because those choices are being threatened by lobbyists representing drug companies, medical trade associations and public health officials, who are trying to persuade legislators to strip all vaccine exemptions from public health laws.

Signing up for NVIC's free Advocacy Portal at www.NVICAdvocacy.org gives you immediate, easy access to your own state legislators on your Smart Phone or computer so you can make your voice heard. You will be kept up-to-date on the latest state bills threatening your vaccine choice rights and get practical, useful information to help you become an effective vaccine choice advocate in your own community. Also, when national vaccine issues come up, you will have the up-to-date information and call to action items you need at your fingertips.

So please, as your first step, sign up for the NVIC Advocacy Portal.

Share Your Story with the Media and People You Know

If you or a family member has suffered a serious vaccine reaction, injury or death, please talk about it. If we don't share information and experiences with each other, everybody feels alone and afraid to speak up. Write a letter to the editor if you have a different perspective on a vaccine story that appears in your local newspaper. Make a call in to a radio talk show that is only presenting one side of the vaccine story.

I must be frank with you; you have to be brave because you might be strongly criticized for daring to talk about the "other side" of the vaccine story. Be prepared for it and have the courage to not back down. Only by sharing our perspective and what we know to be true about vaccination will the public conversation about vaccination open up so people are not afraid to talk about it.

We cannot allow the drug companies and medical trade associations funded by drug companies or public health officials promoting forced use of a growing list of vaccines to dominate the conversation about vaccination. The vaccine injured cannot be swept under the carpet and treated like nothing more than "statistically acceptable collateral damage" of national one-size-fits-all mandatory vaccination policies that put way too many people at risk for injury and death. We shouldn't be treating people like guinea pigs instead of human beings.

Internet Resources Where You Can Learn More

I encourage you to visit the website of the non-profit charity, the National Vaccine Information Center (NVIC), at www.NVIC.org:

• NVIC Memorial for Vaccine Victims: View descriptions and photos of children and adults, who have suffered vaccine reactions, injuries and deaths. If you or your child experiences an adverse vaccine event, please consider posting and sharing your story here.
• If You Vaccinate, Ask 8 Questions: Learn how to recognize vaccine reaction symptoms and prevent vaccine injuries.
• Vaccine Freedom Wall: View or post descriptions of harassment and sanctions by doctors, employers, school and health officials for making independent vaccine choices.

Connect with Your Doctor or Find a New One That Will Listen and Care

If your pediatrician or doctor refuses to provide medical care to you or your child unless you agree to get vaccines you don't want, I strongly encourage you to have the courage to find another doctor. Harassment, intimidation, and refusal of medical care is becoming the modus operandi of the medical establishment in an effort to stop the change in attitude of many parents about vaccinations after they become truly educated about health and vaccination.

However, there is hope.

At least 15 percent of young doctors recently polled admit that they're starting to adopt a more individualized approach to vaccinations in direct response to the vaccine safety concerns of parents. It is good news that there is a growing number of smart young doctors who prefer to work as partners with parents in making personalized vaccine decisions for children, including delaying vaccinations or giving children fewer vaccines on the same day or continuing to provide medical care for those families who decline use of one or more vaccines.

So take the time to locate a doctor who treats you with compassion and respect, and is willing to work with you to do what is right for your child.

Related articles

• FDA Pertussis Vaccine Study Shatters Illusion of Vaccine-Induced Immunity
• Our Efforts to Prevent Heart Disease
• Alzheimer's Advances; Early Detection Test Using Peanut Butter
• WebMD Pockets Millions to Stimulate $1 Trillion in Drug Sales
• Tree Nuts, Chockfull of Healthful Fats, May Help You Live Longer
• FDA Sued, Forced to Remove Safety Status on Trans Fats